Biocon Partners With Voluntis On Digital Therapeutics For Diabetics
Insulia Digital Tool To Be Paired With Biocon Insulins
The global collaboration agreement pairs Biocon’s insulins with Voluntis’s Insulia, the first digital therapeutic with regulatory clearance for insulin-dependent type 2 diabetes patients. Biocon further reveals plans for a complete digital therapeutics portfolio for patients
